Bacil Pharma Limited has announced the incorporation of a new wholly-owned subsidiary, BACIL RESEARCH & DEVELOPMENT PRIVATE LIMITED.

This strategic move creates a dedicated entity focused on the company's research and development initiatives.

For shareholders, this signals an expansion of the company's operational structure, aiming to drive innovation and potentially unlock new growth avenues within its business.